Evaluating immune responses to pneumococcal vaccines
Journal
Asia Pacific Allergy
Year
2023
Conclusion
With the expanding pipeline of PCV vaccines with improved immunogenicity to reduce the morbidity and mortality associated with pneumococcal disease across all ages, vaccine-resistant serotypes may paradoxically emerge. The increasing diversity, heterogeneity, and complexity of IEI in children and adults makes it imperative for clinical immunologists/allergists to continue to deepen their understanding of the immunology surrounding pneumococcal vaccines. Both PPSV and PCV continue to play major roles in the diagnosis of IEI and the prevention of pneumococcal disease in patients at high risk of IPD.
Resources and Links
Phone Number: +603 2781 4519 / +603 2781 4520
Share the Page
|
Information
Consultant Name
Dr Amir Hamzah Abdul Latiff
For general questions about clinical trials
Phone Number: +603 2781 4519 / +603 2781 4520
Clinical trials are part of research studies involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions. They are critical to the advancement of medicine and improving patient health. Participating in clinical trials offers patients the opportunity to try new and effective treatments that could potentially improve their condition while taking part in vital research that can benefit many future patients.
In Pantai Hospital Kuala Lumpur, clinical trials are carried out under our Clinical Research team.
If you would like to participate in any of our clinical trials or would like to know, please provide your information below and we will be in touch with you:
8, Jalan Bukit Pantai, 59100 Kuala Lumpur, Malaysia
.png?sfvrsn=71934c60_8)
.png?sfvrsn=1370dfbd_9)
